EUVIMEDEUVIMED entdecken
Crossref

A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma

Ayano Aso, Hisaki Aiba, Matteo Traversari, Alberto Righi, Marco Gambarotti, Ahmed Atherley O'Meally, Konstantina Solou, Silvia Cammelli, Barbara Bordini, Monica Cosentino, Federica Zuccheri, Barbara Dozza und 5 weitere

Skeletal Radiology · 2024

DOI: 10.1007/s00256-024-04702-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skeletal Radiology, 2024. Verfasst von Ayano Aso und 16 weiteren Autor:innen. Beteiligte Einrichtung: Clinica Ortopedica E Traumatologica III a Prevalente Indirizzo Oncologico, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136, Bologna, Italy. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Neoadjuvant Therapy, Bone Neoplasms, Tumor Burden. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: No consensus exists for tumor volume response criteria in patients with Ewing sarcoma. This study aimed to identify an optimal cutoff for predicting a good histological response by analyzing tumor volume changes and tumor necrosis after neoadjuvant chemotherapy. MATERIALS AND METHODS: We performed a retrospective analysis of 184 Ewing sarcoma patients, analyzing tumor volume changes before and after neoadjuvant chemotherapy. Patients were divided into two groups based on histological response: good (tumor necrosis ≥ 95%) and poor (tumor necrosis < 95%) responders. The receiver operating characteristic (ROC) area under the curve (AUC) method was used to determine the optimal thresholds for predicting the histological response. Additionally, the prognostic value of this cutoff for relapse-free survival was assessed. RESULTS: Out of 184 patients, 83 (45%) had tumor necrosis ≥ 95%, while 101 (55%) had tumor necrosis < 95%. ROC analysis identified the optimal cutoff for a good histological response as over 65% tumor volume reduction (AUC = 0.69; p < 0.001). Patients with volume reduction of ≥ 65% had a higher likelihood of a good histological response than those with lesser reductions (p = 0.004; odds ratio = 2.61). Multivariable analysis indicated a correlation between poor histological response and reduced relapse-free survival (hazard ratio = 2.17; p = 0.01), while tumor volume reduction itself did not impact survival. CONCLUSION: We reported that a tumor volume reduction of ≥ 65% was able to predict a good histological response in Ewing sarcoma patients. We recommend preoperative tumor volume assessment to identify patients at greater risk for poor histological response who could benefit from more intensive chemotherapy protocols or additional radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingNeoadjuvant TherapyBone NeoplasmsTumor BurdenHumansMaleFemaleRetrospective StudiesAdolescentChildAdultPrognosisTreatment OutcomeMagnetic Resonance ImagingChemotherapy, AdjuvantChild, PreschoolYoung Adult

Stichwörter der Autor:innen

Bone tumorEwing sarcomaNeoadjuvant chemotherapyTumor necrosisTumor volume

Autor:innen und Institutionen

  • Clinica Ortopedica E Traumatologica III a Prevalente Indirizzo Oncologico, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136, Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Department of Orthopaedic Surgery, Nagoya City University, Nagoya, Japan.
  • Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Department of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.

Zitieren

APA

Aso, A., Aiba, H., Traversari, M., Righi, A., Gambarotti, M., Atherley O'Meally, A., Solou, K., Cammelli, S., Bordini, B., Cosentino, M., Zuccheri, F., Dozza, B., Frega, G., Ibrahim, T., Manfrini, M., Donati, D. M., & Errani, C. (2024). A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma. Skeletal Radiology. https://doi.org/10.1007/s00256-024-04702-7

Vancouver

Aso A, Aiba H, Traversari M, Righi A, Gambarotti M, Atherley O'Meally A, et al. A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma. Skeletal Radiology. 2024. doi:10.1007/s00256-024-04702-7

BibTeX
@article{Aso2024,
  author = {Aso, Ayano and Aiba, Hisaki and Traversari, Matteo and Righi, Alberto and Gambarotti, Marco and Atherley O'Meally, Ahmed and Solou, Konstantina and Cammelli, Silvia and Bordini, Barbara and Cosentino, Monica and Zuccheri, Federica and Dozza, Barbara and Frega, Giorgio and Ibrahim, Toni and Manfrini, Marco and Donati, Davide Maria and Errani, Costantino},
  title = {A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma},
  journal = {Skeletal Radiology},
  year = {2024},
  doi = {10.1007/s00256-024-04702-7}
}
Kostenlos starten →